Iressa 250 mg

 
Iressa 250 mg Image

Images for reference only. Packaging will vary.


Ask A Pharmacist

Please feel free to ask our pharmacists any questions about Iressa.

Click Here To Ask A Question

Best Value On Brand Iressa 250 mg
Price: $105.95 per tab!
In Stock
Iressa 250 mg Prescription Required
30 tabs for $3,178.65 ($105.95 per tab)
Iressa from online pharmacy: Canada
Guaranteed US Delivery

Iressa 250 mg is available from our online pharmacy for less money than you'd spend locally. If you like the convenience of ordering from your home, you can order your prescription online, or speak with one of our customer service representatives on the phone. Call us, The Drug Company, toll free at 1-888-254-3038. Prior to taking Iressa 250 mg, please consult with your doctor or health professional to see if this medication is right for you. Many customers have saved even more money by speaking with their doctor about a generic substitute.

What is IRESSA and What is Iressa Used for?

IRESSA is a tablet and each tablet contains 250 mg gefitinib.

IRESSA comes in blister packs. Each blister pack contains 30 tablets.

IRESSA has been approved with conditions for the treatment of NSCLC in patients having failed two or more different chemotherapy regimens. NSCLC is one type of lung cancer. No new patients should start IRESSA.

IRESSA targets a protein called Epidermal Growth Factor Receptor (EGFR) and a laboratory test can measure the level of this protein. In patients whose tumours were tested, those with low levels of EGFR appear unlikely to benefit from IRESSA treatment.


Before You Take IRESSA

Do not take IRESSA

  • If you are allergic to gefitinib or any of the other ingredients of IRESSA, listed at the beginning of this leaflet. If you think you may be allergic, ask your doctor for advice.

  • If your tumour has been tested for EGFR expression status and shown to produce low levels of this protein.

Previous illness

Before taking IRESSA, tell your doctor if you have, or have had, serious illness:

  • Particularly lung diseases other than lung cancer. Some of them may worsen during treatment with IRESSA.

Pregnancy

Before taking IRESSA, tell your doctor if you are pregnant or trying to become pregnant. You should avoid becoming pregnant during treatment with IRESSA.

Breast-feeding

Before taking IRESSA, tell your doctor if you are breast-feeding. For the safety of your baby, you should discontinue breast-feeding during treatment with IRESSA.

Driving and operating machinery

IRESSA is not expected to impair your ability to drive or use machines. However, some patients may occasionally feel weak. If this happens, you should not drive or operate machinery.

Taking other medicines

Please inform your doctor if you are taking or have taken any medicines, even those available over the counter.

Your doctor especially needs to know:

  • If you take any of the following medicines: phenytoin, carbamazepine, rifampicin, barbiturates, St John's Wort, itraconazole or grapefruit juice. These medicines may affect the way IRESSA works.

  • If you take warfarin (to prevent blood-clots), as IRESSA may affect it. Your doctor may need to check your blood more often.


How to Take IRESSA

Take one 250 mg tablet, once a day, every day about the same time. You can take IRESSA with or without food.

If you take more IRESSA than you should

  • Talk to your doctor, pharmacist or regional poison control centre immediately.

If you forget to take a dose

  • Take the last missed dose as soon as you remember, as long as it is at least 12 hours before the next dose is due.

  • If it is less than 12 hours to the next dose, do not take the dose you have missed.


Possible Side Effects for Iressa

Like all medicines, IRESSA can have side effects. These are usually mild to moderate in intensity.

Contact your doctor promptly if any of the following happens to you, as you may need further examinations or treatment:

  • Serious breathlessness, or sudden worsening breathlessness, possibly with a cough or fever. Some patients taking IRESSA get an inflammation of the lungs called interstitial lung disease. This side-effect is common (about 1 in every 100 patients are likely to have it), and some of the patients have died from this.

  • Some patients have suffered from dehydration following persistent or severe diarrhoea, vomiting, nausea (feeling sick), or loss of appetite. These side effects are common (1 to 10 of every 100 patients).

  • New eye problems, such as pain, redness or change in vision. Some patients have suffered from ulcer on the surface of the eye (cornea), sometimes with in-growing eyelashes; this side effect is uncommon (less than 1 in every 100 patients).

  • Severe skin reactions affecting large portions of your body including redness, pain, ulcers, blisters, skin sloughing or involvement of lips and mucous membranes (toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme). This type of skin reaction is rare (less than 1 in every 1000 patients is likely to have them).

  • Tarry dark stool, blood in stool, urine, or sputum, or sudden, severe headache.

Tell your doctor if any of the following side effects bother you:

Side effects that are very common (more than 10 of every 100 patients are likely to have them):

  • Diarrhoea

  • Nausea (feeling sick)

  • Skin reactions such as acne-like rash, sometimes itchy with dry skin

  • Red and sore mouth

  • Vomiting

  • Loss of appetite

  • Weakness

Side effects that are common (1 to 10 of every 100 patients are likely to have them):

  • Dehydration

  • Dry mouth

  • Nail problems

  • Loss of hair

  • Dry eye

  • Red and itchy eye

  • Red and sore eyelid

  • Nosebleeds

  • Blood in urine

  • Protein in urine (shown in a urine test)

  • Fever

Bleeding events (for example stomach ulcers or coughing up blood) have been reported in patients taking IRESSA therapy. Patients with tarry dark stool, blood in stool, urine or sputum, or sudden severe headache should contact their physician immediately.

Side effects that are uncommon (less than 1 in every 100 patients is likely to have them):

  • Inflammation of the pancreas, with symptoms such as very severe pain in the upper part of the stomach area and severe nausea (feeling sick) and vomiting.

  • Allergic reactions, including swelling of lips and hives or nettle-rash.

Side effects that are rare (less than 1 in every 1000 patients is likely to have them):

  • Inflammation of the liver. Symptoms may include a general feeling of being unwell, with or without possible jaundice (yellowing of the skin and eyes).

The following side effects can also occur with IRESSA, and they are seen when a blood test is taken:

  • Changes of the levels of liver enzymes and bilirubin. If these levels become very high, your doctor may need to stop the treatment.

  • Changes to the level of one liver enzyme known as alanine aminotransferase (ALT) is very common (more than 10 of every 100 patients).

  • Changes to the level of bilirubin and another liver enzyme known as aspartate aminotransferase (AST) are common (1 to 10 of every 100 patients).

  • Changes to the level of creatinine in your blood, which show how well your kidneys are working. This side effect is common (1 to 10 of every 100 patients).

  • Changes to the way your blood clots, if you are taking warfarin (medicine to prevent blood-clotting). This side effect is uncommon (less than 1 in every 100 patients).

If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist as soon as possible.


Technical Information